Researchers developing tool to combat antibiotic resistance

Image
IANS New York
Last Updated : Jul 29 2017 | 2:28 PM IST

Researchers in the US are in the process of developing a new tool that may help physicians prescribe antibiotics to patients who really need them and avoid giving them to individuals who don't, which may in turn help combat antibiotic resistance.

Although antibiotics helps fight bacterial infections, they are not effective and should not be used to treat viruses, overuse of which leads to antibiotic resistance -- one of the world's most pressing health threats, the researchers said.

"It's extremely difficult to interpret what's causing a respiratory tract infection, especially in very ill patients who come to the hospital with a high fever, cough, shortness of breath and other concerning symptoms," said lead author Ann R. Falsey, Professor at the University of Rochester.

"My goal is to develop a tool that physicians can use to rule out a bacterial infection with enough certainty that they are comfortable, and their patients are comfortable, foregoing an antibiotic," Falsey added.

In the study, the scientists identified 11 genetic markers in blood that can accurately distinguish between viral and bacterial infections, which may help reduce unnecessary use of antibiotics and prevent antibiotic resistance.

"Our genes react differently to a virus than they do to bacteria," explained Thomas J. Mariani, Professor at the varsity.

"Rather than trying to detect the specific organism that's making an individual sick, we're using genetic data to help us determine what's affecting the patient and when an antibiotic is appropriate or not," Mariani said.

For the study, published in the journal Scientific Reports, the team recruited a group of 94 adults hospitalised with lower respiratory tract infections, out of which 41 had a bacterial infection and 53 had a non-bacterial or viral infection.

The researchers used complex genetic and statistical analysis to pinpoint markers in the blood that correctly classified the patients with bacterial infections 80 to 90 per cent of the time.

--IANS

rt/amit/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 29 2017 | 2:18 PM IST

Next Story